Form D · Pharmaceuticals

Delex Healthcare Group, Inc.

New York, NY · CIK 0001909093

Offering snapshot reported Apr 14, 2023 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$1.25K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 14, 2023InitialYet to sellNo comparison0SEC filing
Apr 14, 2023InitialYet to sellNo comparison0SEC filing
Mar 31, 2022InitialYet to sellNo comparison0SEC filing
Mar 29, 2022InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-478854

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Delex Healthcare Group, Inc.None

Source: Form D, filed Apr 14, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Allery Bambao Flores Director, Executive
Ana Lyn Pascual Matienzo Director, Executive
Ma. Lourdes Elvira Primavera Monasterio Director, Executive
Noel Lagare Omandam Director, Executive
J. De Ruyter Coching Oroceo Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
800 Third Avenue Suite A #1359
New York, NY, 10022